cronos group glp-1 receptor agonists weight management diabetes treatments agonism: a transformative approach for managing type-2 and obesity | Saudi Pharmaceutical Journal cronos group glp-1 receptor agonist
Description
S.Honkanen-ScottM.ShawJ.LovatP
The effects of GLP-1 and its analogs on energy expenditure are still inconsistent [48]
Clinical data show that up to 4050% of type 2 diabetes patients demonstrated signs of remission
Cook S, Togni M, Schaub MC, Wenaweser P, Hess OM
Sodium-Glucose Co-Transporter-2 Inhibitors: Peculiar "Hybrid" Diuretics That Protect From Target Organ Damage and Cardiovascular Events
